CNBCLean R·
Pharma stock soars 150% on injectables deal with Wegovy maker Novo
Shares in Swedish microcap stock Nanexa more than doubled after the drug-delivery group revealed a licensing deal with European pharma giant Novo Nordisk.
Read at CNBC →
Shares in Swedish microcap stock Nanexa more than doubled after the drug-delivery group revealed a licensing deal with European pharma giant Novo Nordisk.
<iframe src="https://statesidedaily.com/embed/cluster/ea15d74d0e7fbb6e17eb9d7f9c02baf2c233e993" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Pharma stock soars 150% on injectables deal with Wegovy maker Novo"></iframe>